Pressmeddelande

Correction: PCI Biotech: Mandatory notification regarding trade of shares

GlobeNewswire Publicerad: 08 Sep 2022 11:58

Borkenholm AS has on 8 September 2022 purchased 4,000 shares in PCI Biotech Holding ASA ("PCI Biotech") at an average price of NOK 1.948 per share. Borkenholm AS is a related party to board member Hilde Furberg.

After the transaction, Hilde Furberg and her related parties holds 8,000 shares in PCI Biotech.

Release updated with attachment.

This information is subject to the disclosure requirements in MAR (regulation (EU) No. 596/2014 on market abuse) as implemented in Norway in accordance with section 3-1 of the Securities Trading Act.

Attachment

Skjema for melding om transaksjoner Borkenholm AS 08092022

Nyheter om PCI Biotech

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!